500 patients67,039 observations150 daysLIVE

Patient P-03328

Synthetic patientONX-7 · Day 144 · 65–74 · F · baseline S15Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Improving
Discontinuation risk
14%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S15
  2. Day 12 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 18 GI-04 recommendedGI Support Protocol GI-04
  4. Day 19 Patient acceptedStarted GI-04 in the companion
  5. Day 27 GI symptom burden −11% vs expectedGI Support Protocol GI-04
  6. Day 33 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 12.

Primary contributors, last 14 days
  • GI instability-14
  • Nutritional resilience+6
  • Toxicity+5
  • Treatment adherence-3

What helped?

  • GI Support Protocol GI-04Day 18
    Result: symptom burden −11%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Energy level
Daily log
6.5/10
worsening · -0.8 vs previous 14 d
Stress level
Daily log
4.2/10
worsening · +0.8 vs previous 14 d
Pessimism score
Daily log
3.8/10
worsening · +0.2 vs previous 14 d
Sleep quality
Wearable
42/100
worsening · -6.4 vs previous 14 d
Libido
Daily log
4.7/10
worsening · -0.5 vs previous 14 d
HRV
Wearable
36.1 ms
worsening · -4.4 vs previous 14 d
Toxicity
Blood
17.7/100
stable · +0.6 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 74 from the failing basin, 19 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -6.9 next day on high-intake days · n 18
Would not help
  • AD-05 Adherence Support
    only 23% improved among 13 similar
  • Keep fat low
    GI +5.1 next day on high-intake days · n 22
  • Keep lactose low
    GI +4.8 next day on high-intake days · n 17
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Protein
    -6.9supporter · 95%
  • Dietary fat load
    +5.1detractor · 95%
  • Lactose
    +4.8detractor · 95%
  • Histamine load
    +1no signal · 19%
  • Caffeine
    +0.7no signal · 15%
  • Alcohol
    +0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 60
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • WearableHRV 36 ms, trending down
  • Butyrate / short-chain fatty acid production 35
    • MicrobiomeButyrate capacity 39/100
  • Drug metabolism and exposure 35
    • DNADPYD *2A → slower clearance
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 3 · butyrate capacity 39/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
33 ms
Sleep
6.6 h
Steps
3,072
Resting HR
65 bpm
Daily log: GI score 18, nutritional resilience 64, adherence 91.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • A 15-minute walk after lunch
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0310538%S12AD-05no change60
P-0348238%S05AD-05no change67
P-0342437%S12AD-05improved41
P-0311136%S07AD-05no change48
P-0320436%S16AD-05improved48
P-0338033%S16AD-05improved34
P-0315831%S17AD-05no change37
P-0318731%S12AD-05no change80
P-0335131%S07AD-05no change51
P-0336931%S18AD-05no change37
P-0312230%S13AD-05no change40
P-0312930%S18AD-05no change32